/
/
/

Natco Pharma Balance Sheet

Consolidated
Standalone
%

Share Price Live Stats

Open (₹)839.00
Volume (₹)1.83 L
High (₹)841.80
Upper Circuit1,005.95
Low (₹)831.10
Lower Circuit670.65
Prev Close838.30
52W High (₹)1,226.80
Price832.25
52W Low (₹)789.00

Share Market Cap & Key Ratios Overview

M.Cap (₹)15010.30 Cr
Div. Yield (%)0.60
PE Ratio13.12
Debt to Equity0.04
Price to Book1.88
Book Value424.97
EPS (TTM)63.89
Face Value2.00
ROE (%)27.98

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMANSE
DIVISLABNSE
TORNTPHARMNSE
ZYDUSLIFENSE
CIPLANSE
LAURUSLABSNSE
LUPINNSE
MANKINDNSE
DRREDDYNSE
AUROPHARMANSE
NATCOPHARMNSE
LTP
1W Low
1W High
Market cap (₹)
1903-17 (-0.89%)
1900.10
1984.80
4,56,833Cr
9185.5-53.5 (-0.58%)
9087
9467
2,45,426Cr
4873-177 (-3.50%)
4863
5066
1,87,320Cr
1134-57 (-4.79%)
1125.10
1187
1,13,217Cr
1384.2-39.3 (-2.76%)
1376.70
1426.10
1,12,212Cr
1857.1-81.4 (-4.20%)
1811.70
1949
1,01,155Cr
2121.3-50.2 (-2.31%)
2118.10
2192
97,626Cr
2342.3-40.6 (-1.70%)
2341
2419.20
96,859Cr
1161.2-16.8 (-1.43%)
1154.40
1179.90
96,406Cr
1653.4+8.1 (0.49%)
1622.60
1717
93,614Cr
832.25-21.55 (-2.52%)
831.10
863.40
15,010Cr

Key Highlights of Natco Pharma Ltd Balance Sheet

Natco Pharma Ltd balance sheet discloses shareholders' funds of ₹35.8Cr as of 2025-03-31. The company’s equity share capital is at a value of ₹35.8Cr, and the reserves and surplus of the company is ₹7298.1Cr.

The company has its non-current liabilities with total liabilities of ₹8228.9Cr as of 2025-03-31.

The current liabilities are ₹864.6Cr as of 2025-03-31. At the same time, current assets are ₹4688Cr as of 2025-03-31.

Key assets on the balance sheet are non-current investments of ₹565.1Cr and tangible assets of ₹2516.8Cr, provided in the Natco Pharma Ltd financial statements.